Knight Therapeutics | GUD - Current Assets


Knight Therapeutics reported CAD394.84M in Current Assets for its fiscal quarter ending in December of 2025.





Current Assets Change Date
Acasti Pharma USD 21.96M 7.63M Sep/2026
Akebia Therapeutics USD 220.78M 8.77M Sep/2026
Alaunos Therapeutics USD 666K 304K Jun/2026
Aurora Cannabis CAD 393.45M 4M Jun/2026
Avita Medical AUD 28.39M 7.1M Jun/2026
Canopy Growth CAD 506.36M 23.1M Jun/2026
Cronos Group USD 859.31M 52.72M Sep/2026
Dianthus Therapeutics USD 856.04M 41.5M Sep/2026
Ionis Pharmaceuticals USD 2.36B 129.77M Sep/2026
IQVIA Holdings USD 6.45B 225M Sep/2026
Knight Therapeutics CAD 394.84M 5.86M Dec/2025
Moderna USD 7.34B 1.53B Sep/2026
Omeros USD 69.65M 26.53M Jun/2025
Organigram Holdings CAD 280.09M 30M Jun/2026
Organon & Co USD 5.37B 258M Sep/2026
Revvity USD 1.86B 436.33M Sep/2026
Tectonic Therapeutic USD 231.1M 8.79M Jun/2026
Tilray USD 729.32M 28.18M Sep/2025
Viatris USD 10.3B 242.1M Sep/2026
Xeris Pharmaceuticals USD 289.26M 14.51M Sep/2026